Emergency BU Alert BU Medical Campus OPEN Jan. 28, 2015 Boston University Medical Campus will be open Wednesday, Jan. 28, 2015. BUSM classes will be held as scheduled. Staff should check with their managers regarding work schedules. Medical, PA and GMS students who are assigned to inpatient services or clinics are expected to be present, if possible. Students who are assigned to outpatient services should check with their course director or the policy at the clinical site. GMS classes are canceled. Staff should check with their manager regarding their work schedules. The Henry M. Goldman School of Dental Medicine will follow normal school hours. All Patient Treatment Centers will be open for patient care and all classes will be held as scheduled. BU School of Public Health classes are canceled; SPH non-essential staff may telecommute. Employees who are part of the BUMC parking program should park in your assigned lot or garage. The Boston parking ban is still in effect. For updated information, please call the weather/emergency hotline at 617-638-6886 or visit the BU Emergency Communications website at http://www.bu.edu/ehs/comm/

BUMC Transgenic Core has a New Scientific Director

The BUMC Transgenic Core, established in 1995 by Dr. Katya Ravid, has played an important role in the activities of many scientists at our institution. As part of the continual evaluation of all cores, a faculty committee was established to advise Provost Antman and me on the future role of transgenic services at BUMC.

The committee members were unanimously in favor of maintaining a Transgenic Core facility at BU and increasing its capabilities to serve a larger user group. While the committee recognized that implementation of this recommendation will require new investment at a time of fiscal uncertainty, they were convinced that a transgenic core providing state-of-the-art services is essential for maintaining and growing the University’s research portfolio.

After careful consideration of her many leadership commitments, Dr. Ravid has chosen to step down as Scientific Director of the core because of conflicting time commitments. We would like to thank Dr. Ravid for her creative work and efforts on behalf of the institution in establishing and directing the core over the past 20 years. Her insights and efforts contributed to the success of many research projects and grants at BU.

Dr. Kenn Albrecht, a developmental geneticist with broad expertise in the creation and analysis of mouse models of human disease and a collaborator of Dr. Ravid and the Transgenic Core on multiple projects, has agreed to become the new Scientific Director. Please join me in thanking Dr. Ravid for her efforts and Dr. Albrecht for continuing the mission of the Transgenic Core Facility.

Approaching Deadlines BUMC Featured Funding Opportunities